<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Cell Division - Latest articles</title>
		<link>http://www.celldiv.com</link>
		<description>The latest articles from Cell Division (ISSN 1747-1028) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/8"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/7"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/6"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/5"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/4"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/3"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/2"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/3/1/1"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/2/1/29"/>			    
            
				    <rdf:li rdf:resource="http://www.celldiv.com/content/2/1/28"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.celldiv.com/content/3/1/8">
            
            <title>The many faces of ubiquitinated histone H2A: insights from the DUBs</title>
			<description>Monoubiquitination of H2A is a major histone modification in mammalian cells. Understanding how monoubiquitinated H2A (uH2A) regulates DNA-based processes in the context of chromatin is a challenging question. Work in the past years linked uH2A to transcriptional repression by the Polycomb group proteins of developmental regulators. Recently, a number of mammalian deubiquitinating enzymes (DUBs) that catalyze the removal of ubiquitin from H2A have been discovered. These studies provide convincing evidence that H2A deubiquitination is connected with gene activation. In addition, uH2A regulatory enzymes have crucial roles in the cellular response to DNA damage and in cell cycle progression. In this review we will discuss new insights into uH2A biology, with emphasis on the H2A DUBs.</description>
			<link>http://www.celldiv.com/content/3/1/8</link>
			
			 	<dc:creator>Joseph HA Vissers, Francesco Nicassio, Maarten van Lohuizen, Pier Paolo Di Fiore and Elisabetta Citterio</dc:creator>
			
			<dc:source>Cell Division 2008, 3:8</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-8</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/3/1/7">
            
            <title>Cullin-RING ubiquitin ligases: global regulation and activation cycles</title>
			<description>Cullin-RING ubiquitin ligases (CRLs) comprise the largest known category of ubiquitin ligases. CRLs regulate an extensive number of dynamic cellular processes, including multiple aspects of the cell cycle, transcription, signal transduction, and development. CRLs are multisubunit complexes composed of a cullin, RING H2 finger protein, a variable substrate-recognition subunit (SRS), and for most CRLs, an adaptor that links the SRS to the complex. Eukaryotic species contain multiple cullins, with five major types in metazoa. Each cullin forms a distinct class of CRL complex, with distinct adaptors and/or substrate-recognition subunits. Despite this diversity, each of the classes of CRL complexes is subject to similar regulatory mechanisms. This review focuses on the global regulation of CRL complexes, encompassing: neddylation, deneddylation by the COP9 Signalosome (CSN), inhibitory binding by CAND1, and the dimerization of CRL complexes. We also address the role of cycles of activation and inactivation in regulating CRL activity and switching between substrate-recognition subunits.</description>
			<link>http://www.celldiv.com/content/3/1/7</link>
			
			 	<dc:creator>Dimple R Bosu and Edward T Kipreos</dc:creator>
			
			<dc:source>Cell Division 2008, 3:7</dc:source>
			<dc:date>2008-02-18</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-7</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/3/1/6">
            
            <title>Genetic analysis of the spindle checkpoint genes san-1, mdf-2, bub-3 and the CENP-F homologues hcp-1 and hcp-2 in Caenorhabditis elegans</title>
			<description>Background:
The spindle checkpoint delays the onset of anaphase until all sister chromatids are aligned properly at the metaphase plate. To investigate the role san-1, the MAD3 homologue, has in Caenorhabditis elegans embryos we used RNA interference (RNAi) to identify genes synthetic lethal with the viable san-1(ok1580) deletion mutant.
Results:
The san-1(ok1580) animal has low penetrating phenotypes including an increased incidence of males, larvae arrest, slow growth, protruding vulva, and defects in vulva morphogenesis. We found that the viability of san-1(ok1580) embryos is significantly reduced when HCP-1 (CENP-F homologue), MDF-1 (MAD-1 homologue), MDF-2 (MAD-2 homologue) or BUB-3 (predicted BUB-3 homologue) are reduced by RNAi. Interestingly, the viability of san-1(ok1580) embryos is not significantly reduced when the paralog of HCP-1, HCP-2, is reduced. The phenotype of san-1(ok1580);hcp-1(RNAi) embryos includes embryonic and larval lethality, abnormal organ development, and an increase in abnormal chromosome segregation (aberrant mitotic nuclei, anaphase bridging). Several of the san-1(ok1580);hcp-1(RNAi) animals displayed abnormal kinetochore (detected by MPM-2) and microtubule structure. The survival of mdf-2(RNAi);hcp-1(RNAi) embryos but not bub-3(RNAi);hcp-1(RNAi) embryos was also compromised. Finally, we found that san-1(ok1580) and bub-3(RNAi), but not hcp-1(RNAi) embryos, were sensitive to anoxia, suggesting that like SAN-1, BUB-3 has a functional role as a spindle checkpoint protein.
Conclusion:
Together, these data suggest that in the C. elegans embryo, HCP-1 interacts with a subset of the spindle checkpoint pathway. Furthermore, the fact that san-1(ok1580);hcp-1(RNAi) animals had a severe viability defect whereas in the san-1(ok1580);hcp-2(RNAi) and san-1(ok1580);hcp-2(ok1757) animals the viability defect was not as severe suggesting that hcp-1 and hcp-2 are not completely redundant.</description>
			<link>http://www.celldiv.com/content/3/1/6</link>
			
			 	<dc:creator>Vinita A Hajeri, Anil M Stewart, Landon L Moore and Pamela A Padilla</dc:creator>
			
			<dc:source>Cell Division 2008, 3:6</dc:source>
			<dc:date>2008-02-04</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-6</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-04</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/3/1/5">
            
            <title>Emerging roles of the SUMO pathway in mitosis</title>
			<description>SUMO proteins are small ubiquitin-like modifiers found in all eukaryotes that become covalently conjugated to other cellular proteins. The SUMO conjugation pathway is biochemically similar to ubiquitin conjugation, although the enzymes within the pathway act exclusively on SUMO proteins. This post-translational modification controls many processes. Here, I will focus on evidence that SUMOylation plays a critical role(s) in mitosis: Early studies showed a genetic requirement for SUMO pathway components in the process of cell division, while later findings implicated SUMOylation in the control of mitotic chromosome structure, cell cycle progression, kinetochore function and cytokinesis. Recent insights into the targets of SUMOylation are likely to be extremely helpful in understanding each of these aspects. Finally, growing evidence suggests that SUMOylation is a downstream target of regulation through Ran, a small GTPase with important functions in both interphase nuclear trafficking and mitotic spindle assembly.</description>
			<link>http://www.celldiv.com/content/3/1/5</link>
			
			 	<dc:creator>Mary Dasso</dc:creator>
			
			<dc:source>Cell Division 2008, 3:5</dc:source>
			<dc:date>2008-01-24</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-5</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/3/1/4">
            
            <title>Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction</title>
			<description>Mammalian polo-like kinase 1 (Plk1) has been studied extensively as a critical element in regulating various mitotic events during M-phase progression. Plk1 function is spatially regulated through the targeting activity of the conserved polo-box domain (PBD) present in the C-terminal non-catalytic region. Recent progress in our understanding of Plk1 localization to the centromeres shows that Plk1 self-regulates its initial recruitment by phosphorylating a centromeric component PBIP1 and generating its own PBD-binding site. Paradoxically, Plk1 also induces PBIP1 delocalization and degradation from the mitotic kinetochores late in the cell cycle, consequently permitting itself to bind to other kinetochore components. Thus, PBIP1-dependent self-recruitment of Plk1 to the interphase centromeres serves as a prelude to the efficient delivery of Plk1 itself to other kinetochore components whose interactions with Plk1 are vital for proper mitotic progression.</description>
			<link>http://www.celldiv.com/content/3/1/4</link>
			
			 	<dc:creator>Kyung S Lee, Doo-Yi Oh, Young H Kang and Jung-Eun Park</dc:creator>
			
			<dc:source>Cell Division 2008, 3:4</dc:source>
			<dc:date>2008-01-23</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-4</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/3/1/3">
            
            <title>Preventing DNA over-replication: a Cdk perspective</title>
			<description>The cell cycle is tightly controlled to ensure that replication origins fire only once per cycle and that consecutive S-phases are separated by mitosis. When controls fail, DNA over-replication ensues: individual origins fire more than once per S-phase (re-replication) or consecutive S-phases occur without intervening mitoses (endoreduplication). In yeast the cell cycle is controlled by a single cyclin dependent kinase (Cdk) that prevents origin licensing at times when it promotes origin firing, and that is inactivated, via proteolysis of its partner cyclin, as cells undergo mitosis. A quantitative model describes three levels of Cdk activity: low activity allows licensing, intermediate activity allows firing but prevents licensing, and high activity promotes mitosis. In higher eukaryotes the situation is complicated by the existence of additional proteins (geminin, Cul4-Ddb1Cdt2, and Emi1) that control licensing. A current challenge is to understand how these various control mechanisms are co-ordinated and why the degree of redundancy between them is so variable. Here the experimental induction of DNA over-replication is reviewed in the context of the quantitative model of Cdk action. Endoreduplication is viewed as a consequence of procedures that cause Cdk activity to fall below the threshold required to prevent licensing, and re-replication as the result of procedures that increase that threshold value. This may help to explain why over-replication does not necessarily require reduced Cdk activity and how different mechanisms conspire to prevent over-replication. Further work is nevertheless required to determine exactly how losing just one licensing control mechanism often causes over-replication, and why this varies between cell systems.</description>
			<link>http://www.celldiv.com/content/3/1/3</link>
			
			 	<dc:creator>Andrew CG Porter</dc:creator>
			
			<dc:source>Cell Division 2008, 3:3</dc:source>
			<dc:date>2008-01-22</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-3</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/3/1/2">
            
            <title>Human 14-3-3 gamma protein results in abnormal cell proliferation in the developing eye of Drosophila melanogaster</title>
			<description>Background:
14-3-3 proteins are a family of adaptor proteins that participate in a wide variety of cellular processes. Recent evidence indicates that the expression levels of these proteins are elevated in some human tumors providing circumstantial evidence for their involvement in human cancers. However, the mechanism through which these proteins act in tumorigenesis is uncertain.
Results:
To determine whether elevated levels of 14-3-3 proteins may perturb cell growth we overexpressed human 14-3-3 gamma (h14-3-3 gamma) in Drosophila larvae using the heat shock promoter or the GMR-Gal4 driver and then examined the effect that this had on cell proliferation in the eye imaginal discs of third instar larvae. We found that induction of h14-3-3 gamma resulted in the abnormal appearance of replicating cells in the differentiating proneural photoreceptor cells of eye imaginal discs where h14-3-3 gamma was driven by the heat shock promoter. Similarly, we found that driving h14-3-3 gamma expression specifically in developing eye discs with the GMR-Gal4 driver resulted in increased numbers of replicative cells following the morphogenetic furrow. Interestingly, we found that the effects of overexpressing h1433 gamma on eye development were increased in a genetic background where String (cdc25) function was compromised.
Conclusion:
Taken together our results indicate that h14-3-3 gamma can promote abnormal cell proliferation and may act through Cdc25. This has important implications for 14-3-3 gamma as an oncogene as it suggests that elevated levels of 14-3-3 may confer a growth advantage to cells that overexpress it.</description>
			<link>http://www.celldiv.com/content/3/1/2</link>
			
			 	<dc:creator>Sophia W Hong, Wenqing Qi, Marc Brabant, Giovanni Bosco and Jesse D Martinez</dc:creator>
			
			<dc:source>Cell Division 2008, 3:2</dc:source>
			<dc:date>2008-01-14</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-2</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>2</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/3/1/1">
            
            <title>The ubiquitin E3 ligase activity of BRCA1 and its biological functions</title>
			<description>The basal-like breast cancer, a new category of breast cancer associated with poor prognosis and possibly unique chemosensitivity, is a current topic in the breast cancer field. Evidence from multiple sources strongly indicate that impairment of BRCA1 pathways is responsible for this phenotype, implying the importance of BRCA1 not only in familial breast cancers but also in sporadic cancers. BRCA1 acts as a hub protein that coordinates a diverse range of cellular pathways to maintain genomic stability. BRCA1 participates in multiple cellular supercomplexes to execute its tasks and, in most of the complexes, BRCA1 exists as a RING heterodimer with BARD1 to provide ubiquitin E3 ligase activity that is required for its tumor suppressor function. It was revealed recently that the BRCA1 RING finger is capable of catalyzing multiple types of ubiquitination depending upon the interacting E2, the ubiquitin carrier protein. BRCA1 may catalyze distinct ubiquitination on different substrates as the situation demands. On the other hand, in response to DNA double-strand breaks where BRCA1 plays its major role for homologous recombination repair, recent evidence showed that ubiquitination is a critical step to recruit BRCA1 to the damaged site through UIM (ubiquitin interacting motif) containing protein RAP80. Thus, ubiquitin and BRCA1 likely affect each other in many ways to perform cellular functions. Elucidation of this mechanism in relation to cell survival is now much anticipated because it could be a key to predict chemosensitivity of basal-like breast cancer.</description>
			<link>http://www.celldiv.com/content/3/1/1</link>
			
			 	<dc:creator>Wenwen Wu, Ayaka Koike, Takashi Takeshita and Tomohiko Ohta</dc:creator>
			
			<dc:source>Cell Division 2008, 3:1</dc:source>
			<dc:date>2008-01-07</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-3-1</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>1</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/2/1/29">
            
            <title>Obituary: Arun Fotedar</title>
			<description>-</description>
			<link>http://www.celldiv.com/content/2/1/29</link>
			
			 	<dc:creator>Rati Fotedar and Robert L Margolis</dc:creator>
			
			<dc:source>Cell Division 2007, 2:29</dc:source>
			<dc:date>2007-10-02</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-2-29</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>29</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-10-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.celldiv.com/content/2/1/28">
            
            <title>Membrane-elution analysis of content of cyclins A, B1, and E during the unperturbed mammalian cell cycle</title>
			<description>Background:
Problems with whole-culture synchronization methods for the study of the cell cycle have led to the need for an analysis of protein content during the cell cycle of cells that have not been starved or inhibited. The membrane-elution method is a method that allows the study of the cell cycle by producing a culture of unperturbed, synchronized cells.
Results:
The Helmstetter membrane-elution method for the continuous production of newborn, unperturbed, mammalian cells has been enhanced so that the collection of cells of different cell cycle ages is automated, reproducible, and relatively inexpensive. We have applied the automated membrane-elution method to the analysis of cyclin content during the cell cycle. Cyclin E protein was invariant during the cell cycle. Cyclins B1 and A accumulated continuously during the cell cycle and were degraded at mitosis. Newborn cells had ~0.5% of the cyclin B1 content of dividing cells.
Conclusion:
The expression patterns of cyclins A, B1, and E can be explained by constant mRNA levels during the cell cycle. Previously reported phase specific variations of the cyclins are not strictly necessary for cell-cycle progression. Cells produced by membrane-elution are available to other laboratories for analysis of the cell cycle.</description>
			<link>http://www.celldiv.com/content/2/1/28</link>
			
			 	<dc:creator>Stephen Cooper, Michelle Paulsen, Mats Ljungman, Dang Vu-Phan, Duyang Kim and Mariam Gonzalez-Hernandez</dc:creator>
			
			<dc:source>Cell Division 2007, 2:28</dc:source>
			<dc:date>2007-09-24</dc:date>
			<dc:identifier>doi:10.1186/1747-1028-2-28</dc:identifier>
			
			
							
					<prism:publicationName>Cell Division</prism:publicationName>
					
			
							
					<prism:issn>1747-1028</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>28</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-09-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
